Evidence-Based Complementary and Alternative Medicine

Traditional Chinese Medicine in Ischemia-Reperfusion Injury 2022


Publishing date
01 Dec 2022
Status
Published
Submission deadline
12 Aug 2022

Lead Editor

1Southern University of Science and Technology, Shenzhen, China

2University of Southern California, Los Angeles, USA

3Emory University School of Medicine, Atlanta, USA


Traditional Chinese Medicine in Ischemia-Reperfusion Injury 2022

Description

Clinically, reperfusion in ischemic tissue usually leads to morbidity and mortality in a wide range of pathological and surgical processes, including myocardial infarction, ischemic stroke, acute kidney injury, trauma, organ transplantation, and cardiothoracic, vascular, and general surgery.

Mechanistically, ischemia-reperfusion injury is associated with an enhanced production of inflammatory mediators, emigration of leukocytes in postcapillary venules, vascular protein leakage, activation of innate and adaptive immune responses, and cell death programs. Unfortunately, current medical strategies do not thoroughly diagnose and prevent this disease. Traditional Chinese medicine (TCM) contains numerous bioactive ingredients, some of which show activity against inflammatory mediators, inappropriate immune responses, and cell death.

This Special Issue invites research clinicians and scientists to submit original articles as well as reviews providing a comprehensive overview and high-quality research of TCM in ischemia-reperfusion injury. The work can evaluate the efficacy and safety of TCM for any kind of ischemia-reperfusion injury. We are particularly interested in manuscripts that report the physiological effects as well as the underlying mechanisms of TCM for ischemia-reperfusion injury.

Potential topics include but are not limited to the following:

  • Systematic review and/or meta-analysis of the use of TCM for ischemia-reperfusion injury
  • Biological and pharmacological activity of TCM for ischemia-reperfusion injury prevention and therapy
  • In vitro and in vivo study and toxicity evaluation of TCM for ischemia-reperfusion injury prevention and therapy
  • Active component screening of traditional medicine in ischemia-reperfusion injury prevention and therapy
  • Characterization of active ingredients in herbal plants that have prevention and therapy properties for ischemia-reperfusion injury
  • Quality control of effective Chinese herbs for ischemia-reperfusion injury prevention and therapy
  • Clinical trials on TCM for pain management ischemia-reperfusion injury prevention and therapy
  • Integrative applications of traditional medicine and modern medicine in ischemia-reperfusion injury prevention and therapy
  • Omics of traditional medicine in ischemia-reperfusion injury prevention and therapy
  • Challenges in the use of traditional medicine in ischemia-reperfusion injury prevention and therapy

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 9754181
  • - Retraction

Retracted: Efficacy of Fuyuan Xingshen Decoction Combined with Butylphthalide Sodium Chloride Injection in the Treatment of Acute Cerebral Infarction and Its Effect on Hemodynamics

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9864685
  • - Retraction

Retracted: The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9807212
  • - Retraction

Retracted: Relationship between Prognosis with Dynamic Changes of Thyroid Hormone and Cortisol Hormone in Patients with Severe Craniocerebral Injury

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9763403
  • - Retraction

Retracted: Role of miR-584-5p in Lipopolysaccharide-Stimulated Human Bronchial Epithelial Cell Inflammation and Apoptosis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9757912
  • - Retraction

Retracted: Clinical Observation of Alternative Wave Electroacupuncture Combined with Lee’s Naprapathy in Treating Knee Osteoarthritis (Blood Stasis due to Qi Stagnation)

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9851268
  • - Retraction

Retracted: Wild Bitter Melon Extract Abrogates Hypoxia-Induced Cell Death via the Regulation of Ferroptosis, ER Stress, and Apoptosis in Microglial BV2 Cells

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9826932
  • - Retraction

Retracted: Sulforaphane Ameliorates Limb Ischemia/Reperfusion-Induced Muscular Injury in Mice by Inhibiting Pyroptosis and Autophagy via the Nrf2-ARE Pathway

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9781951
  • - Retraction

Retracted: Protective Effect and Mechanism of Traditional Chinese Medicine on Myocardial Ischemia Reperfusion Injury

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9842493
  • - Retraction

Retracted: Integrated Microarray Analysis to Identify Genes and Small-Molecule Drugs Associated with Stroke Progression

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9780564
  • - Retraction

Retracted: Application of Nursing Outcome-Oriented Integrated Zero-Defect Nursing Combined with Respiratory Function Training in Long-Term Bedridden Patients Undergoing Stroke

Evidence-Based Complementary and Alternative Medicine

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.